Frailty Measure Predicts Mortality Risk Among People with Lupus
March 11, 2019
A new study published in Arthritis & Rheumatology by many top lupus clinicians found that a frailty...
News
Reducing B Cells with Modified CAR T Cells is an Effective Treatment of Experimental Lupus: Shows Study Supported by Lupus Research Alliance
NEW YORK, NY. March 6, 2019. Depleting the number of harmful B cells with a novel immunotherapy that employs...
Lupus Therapeutics to Test Potential Treatment for Lupus in Takeda Collaboration
New York, NY– March 1. The Lupus Research Alliance and clinical affiliate, Lupus Therapeutics will partner with Takeda Pharmaceutical Company...
Lupus Research Alliance Congratulates NIH on 5-Year AMP Success
February 28, 2019
NEW YORK, NY. As a co-sponsor of the National Institutes of Health (NIH) public-private Accelerating Medicines Partnership...
Positive Early Results for BIIB059 as New Treatment Strategy
February 28, 2019
Proteins of the immune system, known as type I interferons, are responsible in part for manifestations of...
LRA-funded Research Backs New Lupus Nephritis Clinical Trial
February 28, 2019
The biotechnology company Equillium Inc. just announced plans for a Phase 1 study to test the investigational...
Bacteria in the Gut May be a Cause of Lupus and Flares: Shows Study Supported by Lupus Research Alliance
NEW YORK, NY. February 19. Pieces of bacteria that escape from the intestines may trigger lupus and associated disease...
Stelara® and Olumiant® Considered Promising by Lupus Expert
February 19, 2019
In Healio Rheumatology, Dr. Gregg Silverman, professor of medicine and pathology at NYU School of Medicine, provided...
New Approach to Treating Lupus Nephritis
February 6, 2019
Scientists partly funded by the Lupus Research Alliance have found a potential new way to protect the...
Protein Osteopontin Indicator of Lupus Nephritis, Shows Clinical Trial
February 1, 2019
Raised levels of a protein osteopontin were shown to indicate lupus nephritis and higher disease activity, in...
Lupus Therapeutics Launches Peer Training Program to Help Patients Benefit from Clinical Trials
NEW YORK, NY. February 1, 2019. Lupus Research Alliance clinical affiliate Lupus Therapeutics launched the Patient Advocates for Lupus Studies...
Overcoming Challenges to Lupus Management
January 24, 2019
A recent review article in Lupus Science & Medicine provides a valuable overview of the “10 most...